Foreign Pharma Growing Vocal against Japan’s Pricing Policy, Flags Return of Drug Lag

The Japan presidents of foreign pharma companies are no longer hiding their concerns about the stagnation of drug development in the Japanese market. In their business briefings for 2021, many of them made explicit criticism against what they see as...read more